A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery

NCT03282461 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: ABY-029

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]